Effects of psilocybin-assisted therapy on treatment-resistant depression
Introduction Major depressive disorder is a highly prevalent clinical condition, affecting more than 300 million individuals worldwide. About 1/3 of patients with MDD fail to achieve remission despite treatment with multiple antidepressants and are considered to have treatment-resistant depressio...
Main Authors: | A. Fraga, D. Esteves-Sousa, J. Facucho-Oliveira, M. Albuquerque, M. Costa, P. Espada Dos Santos, N. Moura, A. Moutinho |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-04-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933821018368/type/journal_article |
Similar Items
-
Psilocybin's Emerging Role in Combating Depressive Disorder
by: Anna Jaremek, et al.
Published: (2023-08-01) -
Psilocybin as a new way for depression treatment
by: Mateusz Maciej Pawlicki, et al.
Published: (2024-05-01) -
Psilocybin-Assisted Compassion Focused Therapy for Depression
by: Wendy Pots, et al.
Published: (2022-03-01) -
Psychotherapy with Psilocybin for Depression: Systematic Review
by: Jonathan Joseph Dawood Hristova, et al.
Published: (2023-03-01) -
Association of Psilocybin Use in Adolescents with Major Depressive Episode
by: K. Shah, et al.
Published: (2022-06-01)